Tolazamide
Back to searchMolecule Structure
Scientific Name
Tolazamide
Description of the Drug
Tolazamide is a sulfonylurea used in the treatment of non insulin dependent diabetes mellitus.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00839
http://www.drugbank.ca/drugs/DB00839
Brand Name(s)
Tolazamide, Tolinase
Company Owner(s)
Usl Pharma Inc, Sun Pharmaceutical Industries Inc, Cosette Pharmaceuticals Inc, Par Pharmaceutical Inc, Chartwell Rx Sciences Llc, Watson Laboratories Inc, Interpharm Inc, Mylan Pharmaceuticals Inc, Barr Laboratories Inc, Superpharm Corp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Sulfonylurea receptor 1, Kir6.2 | PROTEIN COMPLEX | BLOCKER | CHEMBL2096972 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL34417 |
PharmGKB | PA164774902 |
Human Metabolome Database | HMDB0014977 |
DrugBank | DB00839 |
PubChem: Thomson Pharma | 14850072 |
PubChem | 5503 |
Mcule | MCULE-9265102499 |
LINCS | LSM-2699 |
Nikkaji | J3.663C |
BindingDB | 50240099 |
EPA CompTox Dashboard | DTXSID3021358 |
DrugCentral | 2694 |
ChemicalBook | CB9355686 |
Guide to Pharmacology | 6847 |
rxnorm | TOLAZAMIDE |
ChEBI | 9613 |
ZINC | ZINC000000057512 |